{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,5]],"date-time":"2026-06-05T12:59:25Z","timestamp":1780664365500,"version":"3.54.1"},"reference-count":30,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,2,23]],"date-time":"2023-02-23T00:00:00Z","timestamp":1677110400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000026","name":"National Institute on Drug Abuse","doi-asserted-by":"publisher","award":["R01DA001411"],"award-info":[{"award-number":["R01DA001411"]}],"id":[{"id":"10.13039\/100000026","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000026","name":"National Institute on Drug Abuse","doi-asserted-by":"publisher","award":["R01DA031160"],"award-info":[{"award-number":["R01DA031160"]}],"id":[{"id":"10.13039\/100000026","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000038","name":"U.S. Food and Drug Administration","doi-asserted-by":"publisher","award":["75F40121C00148"],"award-info":[{"award-number":["75F40121C00148"]}],"id":[{"id":"10.13039\/100000038","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100015015","name":"Government of South Australia","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100015015","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["thelancet.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["eClinicalMedicine"],"published-print":{"date-parts":[[2023,4]]},"DOI":"10.1016\/j.eclinm.2023.101902","type":"journal-article","created":{"date-parts":[[2023,3,16]],"date-time":"2023-03-16T07:23:27Z","timestamp":1678951407000},"page":"101902","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"special_numbering":"C","title":["Type of medication therapy for ADHD and stimulant misuse during adolescence: a cross-sectional multi-cohort national study"],"prefix":"10.1016","volume":"58","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3655-0496","authenticated-orcid":false,"given":"Ty S.","family":"Schepis","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kennedy S.","family":"Werner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olivia","family":"Figueroa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vita V.","family":"McCabe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John E.","family":"Schulenberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Phil T.","family":"Veliz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Timothy E.","family":"Wilens","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sean Esteban","family":"McCabe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"11","key":"10.1016\/j.eclinm.2023.101902_bib1","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2019.14344","article-title":"Trends in the prevalence and incidence of attention-deficit\/hyperactivity disorder among adults and children of different racial and ethnic groups","volume":"2","author":"Chung","year":"2019","journal-title":"JAMA Netw Open"},{"issue":"1","key":"10.1016\/j.eclinm.2023.101902_bib2","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1177\/1087054716688534","article-title":"Diagnosis and treatment of ADHD in the United States: update by gender and race","volume":"24","author":"Fairman","year":"2020","journal-title":"J\u00a0Atten Disord"},{"issue":"1","key":"10.1016\/j.eclinm.2023.101902_bib3","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1186\/s12887-017-0971-0","article-title":"Challenges in defining the rates of ADHD diagnosis and treatment: trends over the last decade","volume":"17","author":"Davidovitch","year":"2017","journal-title":"BMC Pediatr"},{"key":"10.1016\/j.eclinm.2023.101902_bib4","doi-asserted-by":"crossref","first-page":"112792","DOI":"10.1016\/j.psychres.2020.112792","article-title":"Trends in incidence rates of diagnosed attention-deficit\/hyperactivity disorder (ADHD) over 12 years in Taiwan: a nationwide population-based study","volume":"284","author":"Huang","year":"2020","journal-title":"Psychiatry Res"},{"issue":"2","key":"10.1016\/j.eclinm.2023.101902_bib5","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1176\/appi.ajp.2011.11030387","article-title":"Stimulant medication use in children: a 12-year perspective","volume":"169","author":"Zuvekas","year":"2012","journal-title":"Am J Psychiatry"},{"issue":"2","key":"10.1016\/j.eclinm.2023.101902_bib6","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/j.acap.2012.01.003","article-title":"Trends in attention deficit hyperactivity disorder ambulatory diagnosis and medical treatment in the United States, 2000-2010","volume":"12","author":"Garfield","year":"2012","journal-title":"Acad Pediatr"},{"issue":"11","key":"10.1016\/j.eclinm.2023.101902_bib7","article-title":"Methylphenidate for children and adolescents with attention deficit hyperactivity disorder (ADHD)","volume":"2015","author":"Storeb\u00f8","year":"2015","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.eclinm.2023.101902_bib8","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.jpsychires.2020.01.006","article-title":"A\u00a0literature review and meta-analysis on the effects of ADHD medications on functional outcomes","volume":"123","author":"Boland","year":"2020","journal-title":"J\u00a0Psychiatr Res"},{"issue":"6","key":"10.1016\/j.eclinm.2023.101902_bib9","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.1016\/j.pcl.2019.08.006","article-title":"Prescription stimulants: from cognitive enhancement to misuse","volume":"66","author":"Wilens","year":"2019","journal-title":"Pediatr Clin North Am"},{"issue":"10222","key":"10.1016\/j.eclinm.2023.101902_bib10","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1016\/S0140-6736(19)33004-1","article-title":"Attention-deficit hyperactivity disorder","volume":"395","author":"Posner","year":"2020","journal-title":"Lancet"},{"issue":"7","key":"10.1016\/j.eclinm.2023.101902_bib11","first-page":"745","article-title":"Characterizing adolescent prescription misusers: a population-based study","volume":"47","author":"Schepis","year":"2008","journal-title":"J\u00a0Am Acad Child Adolesc Psychiatry"},{"issue":"3","key":"10.1016\/j.eclinm.2023.101902_bib12","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1016\/j.jaac.2016.12.008","article-title":"Adolescents' prescription stimulant use and adult functional outcomes: a national prospective study","volume":"56","author":"McCabe","year":"2017","journal-title":"J\u00a0Am Acad Child Adolesc Psychiatry"},{"issue":"12","key":"10.1016\/j.eclinm.2023.101902_bib13","doi-asserted-by":"crossref","first-page":"1272","DOI":"10.1016\/j.jaac.2013.09.005","article-title":"Medical and nonmedical use of prescription stimulants: results from a national multicohort study","volume":"52","author":"McCabe","year":"2013","journal-title":"J\u00a0Am Acad Child Adolesc Psychiatry"},{"issue":"5","key":"10.1016\/j.eclinm.2023.101902_bib14","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1176\/appi.ajp.2008.07091465","article-title":"Age of methylphenidate treatment initiation in children with ADHD and later substance abuse: prospective follow-up into adulthood","volume":"165","author":"Mannuzza","year":"2008","journal-title":"Am J Psychiatry"},{"issue":"9","key":"10.1016\/j.eclinm.2023.101902_bib15","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1176\/appi.ajp.2017.16060686","article-title":"ADHD medication and substance-related problems","volume":"174","author":"Quinn","year":"2017","journal-title":"Am J Psychiatry"},{"issue":"4","key":"10.1016\/j.eclinm.2023.101902_bib16","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1097\/FBP.0000000000000203","article-title":"Chronic atomoxetine treatment during adolescence does not influence decision-making on a rodent gambling task, but does modulate amphetamine's effect on impulsive action in adulthood","volume":"27","author":"Silveira","year":"2016","journal-title":"Behav Pharmacol"},{"key":"10.1016\/j.eclinm.2023.101902_bib17","doi-asserted-by":"crossref","first-page":"108402","DOI":"10.1016\/j.neuropharm.2020.108402","article-title":"Impulsivity traits and neurocognitive mechanisms conferring vulnerability to substance use disorders","volume":"183","author":"Verdejo-Garcia","year":"2021","journal-title":"Neuropharmacology"},{"issue":"5","key":"10.1016\/j.eclinm.2023.101902_bib18","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1007\/s11920-006-0044-9","article-title":"Combination pharmacotherapy for adult ADHD","volume":"8","author":"Adler","year":"2006","journal-title":"Curr Psychiatry Rep"},{"issue":"3","key":"10.1016\/j.eclinm.2023.101902_bib19","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1089\/cap.2020.0162","article-title":"Polypharmacy in the management of attention-deficit\/hyperactivity disorder in children and adolescents: a review and update","volume":"31","author":"Baker","year":"2021","journal-title":"J\u00a0Child Adolesc Psychopharmacol"},{"issue":"2","key":"10.1016\/j.eclinm.2023.101902_bib20","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1080\/15374416.2017.1417860","article-title":"Prevalence of parent-reported ADHD diagnosis and associated treatment among U.S. children and adolescents, 2016","volume":"47","author":"Danielson","year":"2018","journal-title":"J\u00a0Clin Child Adolesc Psychol"},{"key":"10.1016\/j.eclinm.2023.101902_bib21","series-title":"Monitoring the future national survey results on drug use, 1975\u20132020: volume I, secondary school students","first-page":"571","year":"2021"},{"issue":"3","key":"10.1016\/j.eclinm.2023.101902_bib22","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2021.0321","article-title":"Racial disparities in diagnosis of attention-deficit\/hyperactivity disorder in a US national birth cohort","volume":"4","author":"Shi","year":"2021","journal-title":"JAMA Netw Open"},{"key":"10.1016\/j.eclinm.2023.101902_bib23","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.drugalcdep.2016.03.019","article-title":"Early exposure to stimulant medications and substance-related problems: the role of medical and nonmedical contexts","volume":"163","author":"McCabe","year":"2016","journal-title":"Drug Alcohol Depend"},{"issue":"1","key":"10.1016\/j.eclinm.2023.101902_bib24","doi-asserted-by":"crossref","first-page":"37","DOI":"10.3109\/00952990.2013.838961","article-title":"Demographic and socioeconomic correlates of powder cocaine and crack use among high school seniors in the United States","volume":"40","author":"Palamar","year":"2014","journal-title":"Am J Drug Alcohol Abuse"},{"issue":"8","key":"10.1016\/j.eclinm.2023.101902_bib25","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1176\/appi.ajp.2018.17091048","article-title":"Prevalence and correlates of prescription stimulant use, misuse, use disorders, and motivations for misuse among adults in the United States","volume":"175","author":"Compton","year":"2018","journal-title":"Am J Psychiatry"},{"issue":"10","key":"10.1016\/j.eclinm.2023.101902_bib26","doi-asserted-by":"crossref","first-page":"1709","DOI":"10.1080\/10826084.2020.1756856","article-title":"Exposure to medicines in the family medicine cabinet: is it a harbinger of later opioid dependence?","volume":"55","author":"Elliott","year":"2020","journal-title":"Subst Use Misuse"},{"issue":"6","key":"10.1016\/j.eclinm.2023.101902_bib27","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1037\/pha0000386","article-title":"Predicting college student prescription stimulant misuse: an analysis from ecological momentary assessment","volume":"29","author":"Schepis","year":"2021","journal-title":"Exp Clin Psychopharmacol"},{"issue":"5","key":"10.1016\/j.eclinm.2023.101902_bib28","doi-asserted-by":"crossref","first-page":"590","DOI":"10.3390\/brainsci12050590","article-title":"Sex differences in substance use, prevalence, pharmacological therapy, and mental Health in adolescents with attention-deficit\/hyperactivity disorder (ADHD)","volume":"12","author":"Castellano-Garc\u00eda","year":"2022","journal-title":"Brain Sci"},{"issue":"10","key":"10.1016\/j.eclinm.2023.101902_bib29","doi-asserted-by":"crossref","first-page":"1501","DOI":"10.1592\/phco.26.10.1501","article-title":"Illicit use of specific prescription stimulants among college students: prevalence, motives, and routes of administration","volume":"26","author":"Teter","year":"2006","journal-title":"Pharmacotherapy"},{"issue":"3","key":"10.1016\/j.eclinm.2023.101902_bib30","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1111\/camh.12441","article-title":"Presenting problem profiles for adolescents with ADHD: differences by sex, age, race, and family adversity","volume":"26","author":"Coxe","year":"2021","journal-title":"Child Adolesc Ment Health"}],"container-title":["eClinicalMedicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2589537023000792?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2589537023000792?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,11]],"date-time":"2025-11-11T22:17:39Z","timestamp":1762899459000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2589537023000792"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,4]]},"references-count":30,"alternative-id":["S2589537023000792"],"URL":"https:\/\/doi.org\/10.1016\/j.eclinm.2023.101902","relation":{},"ISSN":["2589-5370"],"issn-type":[{"value":"2589-5370","type":"print"}],"subject":[],"published":{"date-parts":[[2023,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Type of medication therapy for ADHD and stimulant misuse during adolescence: a cross-sectional multi-cohort national study","name":"articletitle","label":"Article Title"},{"value":"eClinicalMedicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.eclinm.2023.101902","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"101902"}}